DiaMedica Therapeutics Inc. (DMAC) Financials
DMAC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 58.1 million | 2.5 million |
| 2023-06-30 | 62.1 million | 2.3 million |
| 2023-03-31 | 30.2 million | 3.2 million |
| 2022-12-31 | 34.4 million | 2.6 million |
DMAC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -4.8 million | 425000 |
| 2023-06-30 | -5.0 million | 380000 |
| 2023-03-31 | -5.1 million | 422000 |
| 2022-12-31 | -2.8 million | 411000 |
DMAC Net Income
No data available :(
DMAC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 46.5 million | - | 420000 |
| 2023-06-30 | 40.4 million | - | 440000 |
| 2023-03-31 | 28.7 million | - | 459000 |
| 2022-12-31 | 33.5 million | - | 469000 |
DMAC Shares Outstanding
DMAC Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 10000 | 3.3 million | 1.9 million | - |
| 2023-06-30 | 4000 | 2.5 million | 2.2 million | - |
| 2023-03-31 | 7000 | 3.6 million | 1.9 million | - |
| 2022-12-31 | 32000 | 2.3 million | 1.7 million | - |
DMAC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 5.2 million |
| 2023-06-30 | - | 4.7 million |
| 2023-03-31 | - | 5.5 million |
| 2022-12-31 | - | 6000 |
DMAC
Price: $3
52 week price:
Earnings Per Share: -0.60 USD
P/E Ratio: -4.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 67400
Market Capitalization: 105.5 million